Idiosyncratic Drug-Induced Liver Injury and Trastuzumab Deruxtecan in Breast Cancer: A Case Report
Current Oncology · 2025
DOI: 10.3390/curroncol32110606 ↗Kurz gefasst
Fallbericht in der Zeitschrift Current Oncology, 2025. Verfasst von Camilla Lisanti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Experimental and Clinical Pharmacology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy. Hauptthemen laut MEDLINE: Trastuzumab, Breast Neoplasms, Chemical and Drug Induced Liver Injury, Immunoconjugates. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.
Abstract (Originalsprache)
Trastuzumab deruxtecan (T-DXd) has demonstrated efficacy in HER2-positive and HER2-low breast cancer. Its main safety concern is interstitial lung disease, while clinically relevant hepatotoxicity is rarely reported. In our case report we describe a 49-year-old woman with HER2-positive advanced breast cancer that developed persistent grade 3 transaminase elevations after 2 cycles of T-DXd, refractory to corticosteroid treatment and requiring treatment discontinuation. This case underlines the unpredictable and idiosyncratic nature of T-DXd associated hepatotoxicity and the importance of liver function monitoring. Clinicians should consider DILI in patients with unexplained liver enzyme elevations during therapy. Further studies are needed to clarify mechanisms and risk factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Experimental and Clinical Pharmacology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.
- Department of Medicine (DMED), University of Udine, 33100 Udine, Italy.
- Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.
- Department of Oncologic Radiation Therapy and Diagnostic Imaging, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.
- Pathology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.
ORCID-Profile: Camilla Lisanti, Serena Della Rossa, Lucia Da Ros, Erika Cecchin, Fabio Puglisi
Förderung
- Italian Ministry of Health
Zitieren
APA
Lisanti, C., Della Rossa, S., Zottarelli, E., Vida, R., Bolzonello, S., Da Ros, L., Zdjelar, A., Cecchin, E., Perin, T., & Puglisi, F. (2025). Idiosyncratic Drug-Induced Liver Injury and Trastuzumab Deruxtecan in Breast Cancer: A Case Report. Current Oncology. https://doi.org/10.3390/curroncol32110606
Vancouver
Lisanti C, Della Rossa S, Zottarelli E, Vida R, Bolzonello S, Da Ros L, et al. Idiosyncratic Drug-Induced Liver Injury and Trastuzumab Deruxtecan in Breast Cancer: A Case Report. Current Oncology. 2025. doi:10.3390/curroncol32110606
BibTeX
@article{Lisanti2025,
author = {Lisanti, Camilla and Della Rossa, Serena and Zottarelli, Emma and Vida, Riccardo and Bolzonello, Silvia and Da Ros, Lucia and Zdjelar, Adrian and Cecchin, Erika and Perin, Tiziana and Puglisi, Fabio},
title = {Idiosyncratic Drug-Induced Liver Injury and Trastuzumab Deruxtecan in Breast Cancer: A Case Report},
journal = {Current Oncology},
year = {2025},
doi = {10.3390/curroncol32110606}
}
EUVIMED